CMGIC23011 // NRG-GI008 // McGreevy
Basic Study Information
Purpose:
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to
patients based on the presence or absences of circulating tumor DNA (ctDNA) after
surgery for colon cancer.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Maria McGreevy
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search